Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$134.52
2.311.75%
al cierre: -
$134.57
0.050.04%
After hour: 6:10 PM EDT
Comments
Loading...
Calificaciones de analistas, precios objetivo, pronóstico
NICE Ltd ha un obiettivo di prezzo di consenso pari a $221.39, stabilito in base alle ultime valutazioni degli analisti di 19. Le ultime 3 valutazioni degli analisti sono state rilasciate da Jefferies, JMP Securities y Morgan Stanley il octubre 13, 2025, agosto 26, 2025 y agosto 15, 2025. Con un obiettivo di prezzo medio di $215 tra le Jefferies, JMP Securities y Morgan Stanley, c'è un implicito 59.77% upside per NICE Ltd da queste valutazioni degli analisti.
Firmas de analistas que realizan recomendaciones1
Jefferies
JMP Securities
Morgan Stanley
Rosenblatt
DA Davidson
1calculado a partir de las calificaciones de los analistas
Calificaciones de analistas para NICE
Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
10/13/2025 | 12.95% | Jefferies | → $152 | Reinstates | → Hold | |||
08/26/2025 | 122.93% | JMP Securities | $300 → $300 | Reiterates | Market Outperform → Market Outperform | |||
08/15/2025 | 43.42% | Morgan Stanley | $202 → $193 | Maintains | Overweight | |||
08/15/2025 | 41.19% | Rosenblatt | $190 → $190 | Maintains | Buy | |||
08/14/2025 | 11.47% | DA Davidson | $195 → $150 | Maintains | Neutral | |||
07/29/2025 | 122.93% | JMP Securities | $300 → $300 | Reiterates | Market Outperform → Market Outperform | |||
07/28/2025 | 44.91% | DA Davidson | → $195 | Assumes | → Neutral | |||
06/20/2025 | 44.91% | DA Davidson | $185 → $195 | Maintains | Buy | |||
06/20/2025 | 48.62% | Wedbush | $200 → $200 | Reiterates | Outperform → Outperform | |||
06/18/2025 | 48.62% | RBC Capital | $200 → $200 | Reiterates | Outperform → Outperform | |||
06/18/2025 | 19.64% | Cantor Fitzgerald | $161 → $161 | Reiterates | Neutral → Neutral | |||
06/18/2025 | 122.93% | JMP Securities | $300 → $300 | Reiterates | Market Outperform → Market Outperform | |||
06/18/2025 | 41.19% | Rosenblatt | $190 → $190 | Maintains | Buy | |||
06/13/2025 | 35.25% | Piper Sandler | $153 → $182 | Maintains | Neutral | |||
05/19/2025 | 56.8% | Citigroup | $214 → $211 | Maintains | Buy | |||
05/16/2025 | 48.62% | RBC Capital | $200 → $200 | Reiterates | Outperform → Outperform | |||
05/16/2025 | 122.93% | JMP Securities | $300 → $300 | Reiterates | Market Outperform → Market Outperform | |||
05/16/2025 | 37.47% | DA Davidson | $180 → $185 | Maintains | Buy | |||
05/16/2025 | 19.64% | Cantor Fitzgerald | $161 → $161 | Reiterates | Neutral → Neutral | |||
05/16/2025 | 48.62% | Wedbush | $200 → $200 | Reiterates | Outperform → Outperform | |||
05/16/2025 | 41.19% | Rosenblatt | $180 → $190 | Maintains | Buy | |||
04/24/2025 | 33.76% | Rosenblatt | $200 → $180 | Maintains | Buy | |||
04/16/2025 | 50.11% | Morgan Stanley | $235 → $202 | Maintains | Overweight | |||
04/14/2025 | 33.76% | DA Davidson | $200 → $180 | Maintains | Buy | |||
03/19/2025 | 48.62% | RBC Capital | $200 → $200 | Reiterates | Outperform → Outperform | |||
02/24/2025 | 69.43% | Citigroup | $279 → $228 | Maintains | Buy | |||
02/21/2025 | 48.62% | Wedbush | $250 → $200 | Maintains | Outperform | |||
02/21/2025 | 48.62% | RBC Capital | $260 → $200 | Maintains | Outperform | |||
02/21/2025 | 19.64% | Cantor Fitzgerald | $176 → $161 | Maintains | Neutral | |||
02/21/2025 | 122.93% | Citizens Capital Markets | $300 → $300 | Reiterates | Market Outperform → Market Outperform | |||
02/21/2025 | 48.62% | Rosenblatt | $225 → $200 | Maintains | Buy | |||
02/21/2025 | 67.94% | Barclays | $286 → $226 | Maintains | Overweight | |||
02/18/2025 | 107.33% | Citigroup | $315 → $279 | Maintains | Buy | |||
01/16/2025 | 30.79% | Cantor Fitzgerald | → $176 | Initiates | → Neutral | |||
12/19/2024 | 48.62% | Jefferies | $215 → $200 | Downgrade | Buy → Hold | |||
11/15/2024 | 59.77% | Jefferies | $230 → $215 | Maintains | Buy | |||
11/15/2024 | 67.2% | DA Davidson | $300 → $225 | Maintains | Buy | |||
11/15/2024 | 93.21% | RBC Capital | $260 → $260 | Reiterates | Outperform → Outperform | |||
11/15/2024 | 85.78% | Northland Capital Markets | $275 → $250 | Maintains | Outperform | |||
11/14/2024 | 38.96% | Piper Sandler | $213 → $187 | Downgrade | Overweight → Neutral | |||
11/13/2024 | 148.2% | Citigroup | $330 → $334 | Maintains | Buy | |||
10/03/2024 | 93.21% | RBC Capital | $260 → $260 | Reiterates | Outperform → Outperform | |||
08/16/2024 | 85.78% | Wedbush | $250 → $250 | Reiterates | Outperform → Outperform | |||
08/16/2024 | 93.21% | RBC Capital | $230 → $260 | Maintains | Outperform | |||
08/16/2024 | 122.93% | JMP Securities | $300 → $300 | Reiterates | Market Outperform → Market Outperform | |||
08/16/2024 | 104.35% | Northland Capital Markets | $305 → $275 | Maintains | Outperform | |||
08/16/2024 | 67.2% | Rosenblatt | $225 → $225 | Maintains | Buy | |||
08/13/2024 | 67.2% | Rosenblatt | $225 → $225 | Maintains | Buy | |||
07/25/2024 | 112.53% | Barclays | $320 → $286 | Maintains | Overweight | |||
07/10/2024 | 58.28% | Piper Sandler | $238 → $213 | Maintains | Overweight | |||
06/14/2024 | 78.35% | Morgan Stanley | $290 → $240 | Maintains | Overweight | |||
06/13/2024 | 126.65% | Northland Capital Markets | $305 → $305 | Maintains | Outperform | |||
06/12/2024 | 157.12% | Citigroup | $339 → $346 | Maintains | Buy | |||
06/12/2024 | 122.93% | JMP Securities | $300 → $300 | Reiterates | Market Outperform → Market Outperform | |||
06/12/2024 | 70.91% | RBC Capital | $265 → $230 | Maintains | Outperform | |||
06/12/2024 | 85.78% | Wedbush | → $250 | Reiterates | Outperform → Outperform | |||
06/12/2024 | 122.93% | DA Davidson | $300 → $300 | Maintains | Buy | |||
06/12/2024 | 67.2% | Rosenblatt | $285 → $225 | Maintains | Buy | |||
05/17/2024 | 96.92% | RBC Capital | $285 → $265 | Maintains | Outperform | |||
05/17/2024 | 70.91% | Jefferies | $280 → $230 | Maintains | Buy | |||
05/17/2024 | 122.93% | JMP Securities | $343 → $300 | Maintains | Market Outperform | |||
05/17/2024 | 108.07% | Mizuho | $300 → $280 | Maintains | Buy | |||
05/17/2024 | 100.64% | B of A Securities | $300 → $270 | Maintains | Buy | |||
05/15/2024 | 154.89% | JMP Securities | $343 → $343 | Reiterates | Market Outperform → Market Outperform | |||
04/23/2024 | 111.79% | Rosenblatt | → $285 | Initiates | → Buy | |||
03/13/2024 | 122.93% | DA Davidson | $250 → $300 | Upgrade | Neutral → Buy | |||
03/12/2024 | 122.93% | DA Davidson | $250 → $300 | Upgrade | Neutral → Buy | |||
02/23/2024 | 154.89% | JMP Securities | $343 → $343 | Reiterates | Market Outperform → Market Outperform | |||
02/23/2024 | 148.94% | Citigroup | $334 → $335 | Maintains | Buy | |||
02/23/2024 | 111.79% | RBC Capital | $238 → $285 | Maintains | Outperform | |||
02/23/2024 | 122.93% | Mizuho | $244 → $300 | Maintains | Buy | |||
02/23/2024 | 137.79% | Barclays | $283 → $320 | Maintains | Overweight | |||
02/23/2024 | 100.64% | Wedbush | $230 → $270 | Maintains | Outperform | |||
02/23/2024 | 122.93% | Oppenheimer | $225 → $300 | Maintains | Outperform | |||
02/21/2024 | 148.2% | Citigroup | $283 → $334 | Maintains | Buy | |||
02/01/2024 | 154.89% | JMP Securities | → $343 | Reiterates | Market Outperform → Market Outperform | |||
01/30/2024 | 122.93% | Northland Capital Markets | → $300 | Initiates | → Outperform | |||
01/22/2024 | 154.89% | JMP Securities | $343 → $343 | Reiterates | Market Outperform → Market Outperform | |||
12/18/2023 | 154.89% | JMP Securities | $343 → $343 | Reiterates | Market Outperform → Market Outperform | |||
11/22/2023 | 76.86% | RBC Capital | → $238 | Reiterates | Outperform → Outperform | |||
11/17/2023 | 76.86% | RBC Capital | → $238 | Reiterates | Outperform → Outperform | |||
10/16/2023 | 63.48% | Morgan Stanley | $225 → $220 | Upgrade | Equal-Weight → Overweight | |||
10/09/2023 | 154.89% | JMP Securities | → $343 | Reiterates | Market Outperform → Market Outperform | |||
10/05/2023 | 76.86% | RBC Capital | → $238 | Reiterates | Outperform → Outperform | |||
10/05/2023 | 67.2% | Oppenheimer | $250 → $225 | Maintains | Outperform | |||
09/29/2023 | 41.19% | DA Davidson | → $190 | Initiates | → Neutral | |||
08/18/2023 | 76.86% | RBC Capital | → $238 | Reiterates | Outperform → Outperform | |||
08/18/2023 | 154.89% | JMP Securities | → $343 | Reiterates | Market Outperform → Market Outperform | |||
08/15/2023 | 151.17% | Citigroup | $278 → $338 | Maintains | Buy | |||
07/26/2023 | — | William Blair | — | Initiates | → Outperform | |||
06/14/2023 | 154.89% | JMP Securities | → $343 | Reiterates | Market Outperform → Market Outperform | |||
06/07/2023 | 76.86% | RBC Capital | → $238 | Reiterates | Outperform → Outperform | |||
05/31/2023 | 81.32% | Mizuho | → $244 | Initiates | → Buy | |||
05/12/2023 | 70.91% | Wedbush | $250 → $230 | Maintains | Outperform | |||
05/12/2023 | 74.63% | Jefferies | $260 → $235 | Maintains | Buy | |||
05/10/2023 | 106.58% | Citigroup | $277 → $278 | Maintains | Buy | |||
02/24/2023 | 105.84% | Citigroup | $301 → $277 | Maintains | Buy | |||
01/17/2023 | 68.69% | Piper Sandler | $222 → $227 | Upgrade | Neutral → Overweight | |||
11/11/2022 | 67.2% | Morgan Stanley | $215 → $225 | Maintains | Equal-Weight | |||
11/11/2022 | 93.21% | Citigroup | $254 → $260 | Maintains | Buy |
PREGUNTAS FRECUENTES
¿Cuál es el precio objetivo de las acciones de NICE (NICE)?
El último precio objetivo de NICE (NASDAQ:NICE) fue comunicado por Jefferies el octubre 13, 2025. La firma de analistas fijó un precio objetivo para $152.00 que espera NICE a rise dentro de 12 meses (un posible 12.95% upside). 41 firmas de analistas han reportado calificaciones en el último año.
¿Cuál es la calificación más reciente de los analistas sobre NICE (NICE)?
La última calificación de analistas para NICE (NASDAQ:NICE) fue proporcionada por Jefferies, y NICE su hold calificación.
¿Cuándo se produjo la última revisión al alza de NICE (NICE)?
La última revisión al alza de NICE Ltd se produjo en marzo 13, 2024, cuando DA Davidson elevó su precio objetivo a $300. DA Davidson anteriormente tenía a neutral para NICE Ltd.
¿Cuándo fue la última revisión a la baja de NICE (NICE)?
La última revisión a la baja de NICE Ltd se produjo en diciembre 19, 2024, cuando Jefferies cambió su precio objetivo de $215 a $200 para NICE Ltd.
¿Cuándo se publicará o actualizará la próxima calificación de los analistas para NICE (NICE)?
Los analistas llegan a las calificaciones de acciones después de hacer una investigación exhaustiva, que incluye revisar los estados financieros públicos, hablar con ejecutivos y clientes de NICE, y escuchar las teleconferencias de ganancias. La mayoría de los analistas hacen esto cada tres meses, por lo que deberías recibir 4 calificaciones por empresa al año. La última calificación de NICE se registró el octubre 13, 2025, por lo que la próxima calificación estará disponible en torno al octubre 13, 2026.
¿Es correcta la calificación de los analistas sobre NICE (NICE)?
Aunque las calificaciones son subjetivas y pueden cambiar, la última calificación de NICE (NICE) fue un con un precio objetivo de $0.00 a $152.00. El precio actual al que cotiza NICE (NICE) es de $134.57, que es within del rango previsto por el analista.
Explora calificaciones de analistas y precios objetivo sobre todos los valores.